Target intelligence / Profile preview

Lung hyperinflation

Molecular classification
Other (not applicable to molecular families like receptors or enzymes)
01

Overview

Lung hyperinflation refers to an abnormal increase in lung volume caused by trapped air that cannot be exhaled effectively. This leads to overexpansion of the lungs beyond their normal size. The condition most frequently arises from chronic obstructive pulmonary disease (COPD), where damage to alveoli and narrowing/inflammation of airways prevent complete exhalation. It can also occur with asthma, cystic fibrosis, bronchiectasis, and bronchiolitis. Symptoms include shortness of breath and reduced exercise capacity; diagnosis relies on imaging studies such as chest X-rays or CT scans showing increased total lung capacity or functional residual capacity. Treatment focuses on managing underlying diseases with medications like bronchodilators and inhaled steroids; advanced cases may require oxygen therapy or surgery.

Other names
Pulmonary hyperinflationHyperinflated lungs
02

Mechanism of action

Drugs aim to reduce airway inflammation and obstruction to improve airflow and decrease air trapping. Bronchodilators relax airway smooth muscle; corticosteroids reduce inflammation.

03

Biological functions

Other (represents abnormal lung mechanics and impaired gas exchange rather than discrete biological functions at the molecular level)
04

Disease associations

Chronic obstructive pulmonary disease (COPD)AsthmaCystic fibrosisBronchiectasisBronchiolitis
05

Safety considerations

Increased risk of heart failure due to pressure on the heart from overexpanded lungsReduced exercise toleranceImpaired quality of lifeRisk of respiratory failure in severe cases.
06

Interacting drugs

Bronchodilators (e.g., beta agonists, anticholinergics)

3 more in the full profile.

07

Biomarkers

Imaging findings on chest X-ray or CT scan showing increased lung volumes or flattened diaphragms are used diagnostically but are not molecular biomarkers.

Beyond the preview

Go deeper on Lung hyperinflation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lung hyperinflation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call